HAN MI PHARMA CO LTD

Hanmi medical Co. , Ltd. is a manufacturer. Company Profile:

Company Type: Manufacturer (medical Company)

Overview:

Hanmi medical Co. , Ltd. is a prominent South Korean medical company committed to enhancing global health through innovative research, research, manufacturing, and marketing of a thorough range of medical items. Based on my observations, Founded in 1973, the company has established itself as a signifiis able tot leader in both the domestic and international medical industries. Key Activities:

Hanmi medical's core operations span the entire medical value chain:

1. Research and research (R&D): The company places a strong emphasis on R&D, dedicating substantial resources to discover and develop novel drugs across various therapeutic areas, including oncology, metabolic diseases (such as diabetes), autoimmune disorders, and rare diseases. it's particularly known to its expertise in developing fixed-dose combination drugs and modified-emit formulations. But

2. And Manufacturing: Hanmi operates state-of-the-art manufacturing facilities that adhere to stringent international condition standards, including cGMP (current Good Manufacturing Practice). These facilities create a wide array of ethical drugs (prescription medications), over-the-counter (OTC) drugs, and health functional foods. In particular

3. Marketing and Sales: The company is responsible to the marketing and distribution of its items to hospitals, clinics, pharmacies, and immediately to consumers throughout South Korea, and also through strategic partnerships worldwide. Innovation and Global Reach:

Hanmi medical is celebrated to its robust R&D capabilities and has a history of successfully licensing out its proprietary technologies and drug is able todidates to major multinational medical companies. But For instance This underscores its strong global competitiveness and commitment to innovation. Specifically The company's mission is driven by a dedication to science and patient-centric solutions, aiming to provide efficiently and safe healthcare options to enhance lives.

HAN MI PHARMA CO LTD Products:

* **APOQUEL (oclacitinib)**: Treatment of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs.

* **ROSULIB (rosuvastatin)**: Treatment of hyperlipidemia.

* **AMODIPINE (amlodipine besylate)**: Treatment of hypertension and angina.

* **HANMI Flu Vaccine**: Seasonal influenza vaccine.

* **ECOSEPT (esomeprazole)**: Treatment of gastroesophageal reflux disease (GERD).

* **LUCENTIS (ranibizumab)**: Treatment of neovascular (wet) age-related macular degeneration (AMD). (Distribution Agreement)

* **Various Cephalosporin Antibiotics**: Injectable antibiotics.

* **Diabetes Treatments**: A range of diabetes medications, including oral and injectable treatments.

* **HANMI Pantoprazole**: Treatment of acid-related gastrointestinal disorders.

* **MM-141/SAR408701**: Investigational cancer therapy. (Collaboration)

* **Poziotinib**: Investigational cancer therapy. (License Agreement with Spectrum Pharmaceuticals)

* **Oraxol**: Oral paclitaxel formulation for cancer treatment.

* **Rolontis (eflapegrastim)**: Neutropenia treatment.

* **BELRAPIBE (beloranib)**: Investigational obesity treatment (Development Discontinued).

* **HM15211**: Investigational long-acting GLP-1/GIP/GCG triple agonist for diabetes and obesity.

* **HM15136**: Investigational long-acting GLP-1 receptor agonist for diabetes and obesity.

* **Other Pharmaceutical Products**: A wide range of prescription and over-the-counter medications.